2-amino-5-phosphonovalerate has been researched along with Alloxan Diabetes in 4 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamal, A | 1 |
| Biessels, GJ | 1 |
| Gispen, WH | 1 |
| Ramakers, GM | 1 |
| Calcutt, NA | 1 |
| Chaplan, SR | 1 |
| Zheng, H | 1 |
| Liu, X | 1 |
| Li, Y | 1 |
| Patel, KP | 1 |
| Sasaki-Hamada, S | 1 |
| Sacai, H | 1 |
| Oka, JI | 1 |
4 other studies available for 2-amino-5-phosphonovalerate and Alloxan Diabetes
| Article | Year |
|---|---|
Synaptic transmission changes in the pyramidal cells of the hippocampus in streptozotocin-induced diabetes mellitus in rats.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Diabetes Mellitus, Experimental; Dose-Respon | 2006 |
Spinal pharmacology of tactile allodynia in diabetic rats.
Topics: 2-Amino-5-phosphonovalerate; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Anti-Bacterial A | 1997 |
A Hypothalamic Leptin-Glutamate Interaction in the Regulation of Sympathetic Nerve Activity.
Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Excitatory Amino Acid Antagonists; Gene Kn | 2017 |
Diabetes onset influences hippocampal synaptic plasticity in streptozotocin-treated rats.
Topics: Age Factors; Age of Onset; Analysis of Variance; Animals; Animals, Newborn; Biophysics; Diabetes Mel | 2012 |